All Stories

  1. Aircraft-Assisted Pilot Suicides in the General Aviation Increased for One-Year Period after 11 September 2001 Attack in the United States
  2. Pilot Posttraumatic Stress Disorder and Fatal Aviation Accidents
  3. Challenges in investigation of diabetes-related aviation fatalities—an analysis of 1491 subsequent aviation fatalities in USA during 2011–2016
  4. Duty of Notification and Aviation Safety—A Study of Fatal Aviation Accidents in the United States in 2015
  5. Copycats in Pilot Aircraft-Assisted Suicides after the Germanwings Incident
  6. Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)
  7. Attention-Deficit/Hyperactivity Disorder and Fatal Accidents in Aviation Medicine
  8. Statins for children with familial hypercholesterolemia
  9. The need to establish consistent international safety investigation guidelines for the chemical industries
  10. General Aviation Pilots Over 70 Years Old
  11. Bipolar Disorder in Aviation Medicine
  12. Response to Dr. Gerald M Reaven: good news for patients with familial hypercholesterolaemia: statins are not diabetogenic in this disease
  13. Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?
  14. Statins and new-onset diabetes mellitus - a risk lacking in familial hypercholesterolaemia
  15. On doctors’ accountability and flight deck safety
  16. Evaluation and Treatment of Older Patients With Hypercholesterolemia
  17. Aircraft-Assisted Pilot Suicides: Lessons to be Learned
  18. Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
  19. What fatal occupational accident investigators can learn from fatal aircraft accident investigations
  20. Major Depression and Fitness to Fly by Different Aviation Authorities
  21. Benefits of dietary phytosterols
  22. Cochrane Review: Statins for children with familial hypercholesterolemia
  23. Do statins reduce the incidence of stroke in familial hypercholesterolemia?
  24. Long-Term Statin Therapy is Associated with Better Episodic Memory in Aged Familial Hypercholesterolemia Patients in Comparison with Population Controls
  25. A novel point mutation (Pro84 ← Ser) of the low density lipoprotein receptor gene in a family with moderate hypercholesterolemia
  26. Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge
  27. Squalene and Noncholesterol Sterols in Serum and Lipoproteins of Children with and without Familial Hypercholesterolemia
  28. Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns
  29. Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences
  30. Stanol Ester Margarine Alone and With Simvastatin Lowers Serum Cholesterol in Families With Familial Hypercholesterolemia Caused by the FH–North Karelia Mutation
  31. Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia
  32. A Molecular and Clinical Study of Heterozygous Familial Hypercholesterolemia in the Finnish North Karelia
  33. Neonatal Diagnosis of Familial Hypercholesterolemia in Newborns Born to a Parent With a Molecularly Defined Heterozygous Familial Hypercholesterolemia
  34. Deletions of the low density lipoprotein receptor gene underlying familial hypercholesterolaemia: screening by polymerase chain reaction using pooled DNA and blood samples
  35. Arg 506 Gin Factor V Mutation (Factor V Leiden) in Patients with Familial Hypercholesterolaemia
  36. Cryptosporidium in Asymptomatic Children